| Project |
Year |
Money |
Section |
Category |
| XtalPi Technology’s HKD989m IPO |
2024 |
HKD989 million |
Equity capital markets |
H shares; quantum physics |
| Zeekr’s USD441m NYSE listing |
2024 |
USD441 million |
Equity capital markets |
NYSE; Electric vehicles |
| Alibaba issues USD5bn convertible senior notes |
2024 |
USD5 billion |
Debt capital markets |
Convertible senior notes; internet |
| Alibaba issues USD5bn convertible senior notes |
2024 |
USD5 billion |
Debt capital markets |
Convertible senior notes; internet |
| China MOF’s USD2.18bn sovereign bonds |
2024 |
EUR2 billion |
Debt capital markets |
Sovereign bonds |
| Far East Horizon issues USD500m notes |
2024 |
USD500 million |
Debt capital markets |
USD notes; leasing |
| Kangfu issues Huaneng quasi-REITs |
2024 |
RMB3.8 billion |
ABS/REITS |
Quasi-REIT; power generation |
| China Resources buys JCET stake for USD1.64bn |
2024 |
RMB11.69 billion |
M&A |
Share acquisition; semiconductors |
| Chinese Luxshare buys US Qorvo assets |
2024 |
N/A |
M&A |
M&A; semiconductors |
| Johnson Controls sells HVAC business to Bosch |
2024 |
USD8.1 billion |
M&A |
Acquisition; HVAC |
| LG Display sells LCD business in China |
2024 |
RMB10.8 billion |
M&A |
Manufacturing; cross-border M&A |
| Mindray pays USD927m for APT Medical |
2024 |
RMB6.65 billion |
M&A |
Acquisition; medical device |
| Nuvation Bio secures AnHeart Therapeutics |
2024 |
N/A |
M&A |
Biopharmaceuticals; cross-border M&A |
| PAG-led consortium acquires Zhuhai Wanda |
2024 |
RMB60 billion |
PE/VC |
Financing; real estate |
| China Oriental, ArcelorMittal launch JV |
2024 |
USD2.66 billion |
General corporate matter |
Joint venture; steel |
| CStone partners with Ewopharma |
2024 |
USD51.3 million |
General corporate matter |
Licensing; pharmaceutical |
| Envision, PIF, Vision Industries form JV |
2024 |
N/A |
General corporate matter |
Joint venture; new energy; wind power |
| CIFI offshore liabilities restructuring |
2024 |
USD7 billion |
Liquidation, bankruptcy and restructuring |
Restructuring; real estate |
| First Shanghai-listed company reorganised |
2024 |
N/A |
Liquidation, bankruptcy and restructuring |
Reorganisation; architectural decoration |
| Kaisa offshore debt restructuring |
2024 |
USD16 billion |
Liquidation, bankruptcy and restructuring |
Bankruptcy restructuring; real estate |
| Dreame, Roborock patent dispute |
2024 |
EUR250,000 |
Intellectual property |
Patent; litigation; household appliances |
| Shengtong Bond misrepresentation dispute |
2024 |
N/A |
Domestic dispute resolution |
Misrepresentation |
| Cayman court upholds arbitration injunction |
2024 |
RMB4 billion |
Cross-border dispute resolution |
Shareholder pledges; cross-border injunctive relief |
| Nam Tai Property corporate control dispute |
2024 |
N/A |
Cross-border dispute resolution |
Corporate control dispute; behaviour preservation |
| Japan bankruptcy case a first for China |
2024 |
N/A |
Liquidation, bankruptcy and restructuring |
Bankruptcy; China-Japan trade |
| Hasten Biopharma’s series A financing |
2023 |
USD315 million |
PE/VC |
Financing; biotechnology |
| China Aerospace receives strategic investment |
2023 |
RMB3.8 billion |
PE/VC |
Financing; drone technology |
| AESC’s series B round |
2023 |
USD1 billion |
PE/VC |
Financing; electric vehicles |
| Contract dispute over CERCG US dollar bond |
2023 |
N/A |
Domestic Dispute Resolution |
Guarantee contract disputes; US dollar bonds |
| Kingsoft Cloud’s Hong Kong dual-primary listing |
2023 |
N/A |
Equity Capital Markets |
HKEX cloud computing |
| WuXi XDC Cayman listing in HK |
2023 |
HKD3.68 billion |
Equity Capital Markets |
HKEX; pharmaceuticals |
| Saudi Aramco, Norinco JV to set up refinery complex |
2023 |
N/A |
General Corporate Matter |
Joint venture; construction; energy |
| CEFC: HK courts defer to mainland |
2023 |
N/A |
Liquidation, Bankruptcy And Restructuring |
Liquidation; finance |
| First interbank bond misrepresentation case |
2023 |
N/A |
Domestic Dispute Resolution |
Misrepresentation; interbank market |
| First ABS fraudulent issuance case |
2023 |
N/A |
Domestic Dispute Resolution |
Misrepresentation; intermediary liability |
| Lotus Technology’s SPAC listing on Nasdaq |
2023 |
USD880 million |
Equity Capital Markets |
Nasdaq; SPAC listing; electric vehicles |
| Egypt’s first sustainable panda bond issuance |
2023 |
USD530 million |
Debt Capital Markets |
Panda bonds; sustainable development |
| Cargill sells China poultry unit to DCP Capital |
2023 |
N/A |
M&A |
Private equity; agribusiness |
| China Eastern’s USD2.1bn private A-share placement |
2023 |
RMB15 billion |
Equity Capital Markets |
Private placement; aviation |
| PBOC’s USD19.5bn renminbi bill issuance in Hong Kong |
2023 |
RMB140 billion |
Debt Capital Markets |
Renminbi bill; PBOC |
| ZK Engineering debt mountain resolved |
2023 |
RMB80 billion |
Liquidation, Bankruptcy And Restructuring |
Reorganisation; construction engineering |
| XPeng purchases Didi’s EV unit |
2023 |
HKD5.84 billion |
M&A |
Secondary public offering; electric vehicles |
| Sinosteel merges into China Baowu |
2023 |
RMB100 |
M&A |
State asset reorganisation; Steel industry |
| Volkswagen invests USD700m in Xpeng |
2023 |
USD700 million |
M&A |
Transfer by agreement; electric vehicles |
| Aramco bets on China refining, bags major supply deal |
2023 |
RMB24.6 billion |
M&A |
Transfer by agreement; petrochemicals |
| Abogen Biosciences series C, C+ financing |
2022 |
USD1.02 billion |
Cross-border |
Financing; pharmaceuticals |
| BeiGene’s USD3.2bn IPO on Star Market |
2022 |
USD3.2 billion |
Capital Markets |
Star Market; biotechnology |
| Coca-Cola’s subsidiary disposal in mainland China |
2022 |
N/A |
Cross-border |
M&A; food & beverages |
| Fuguiniao bonds’ misrepresentation of liability |
2022 |
N/A |
Disputes & Investigations |
Capital markets; misrepresentation |
| Huaxin Cement converts B shares to H shares |
2022 |
N/A |
Capital Markets |
Listing transfer; listing by way of introduction |
| Mengniu incentive scheme for onshore employees |
2022 |
HKD4.9 billion |
Cross-border |
Financing; employee incentives |
| Zhongtai Group issues FTZ offshore bonds |
2022 |
RMB760 million |
Capital Markets |
Bonds; free trade zone |
| China Biologic’s Nasdaq delisting |
2021 |
USD4.76 billion |
Capital Markets |
Privatisation; medicine; JunHe |
| Didi Global’s USD4.4bn NYSE IPO |
2021 |
USD4.4 billion |
Capital Markets |
US listing; IPO; internet |
| Founder Group’s USD11bn restructuring |
2021 |
USD11 billion |
Domestic |
Bankruptcy reorganisation |
| HNA Group restructuring |
2021 |
RMB41 billion |
Domestic |
Bankruptcy restructuring; aviation |
| HT Aero’s series A financing |
2021 |
USD500 million |
Domestic |
Financing; new energy |
| MBK’s USD2.2bn acquisition of CAR Inc |
2021 |
USD2.2 billion |
Cross-border |
M&A; privatisation |
| Xpeng’s Hong Kong listing |
2021 |
USD1.8 billion |
Capital Markets |
Hong Kong listing; automotive |
| 58.com’s privatisation |
2020 |
USD8.7 billion |
Overseas Deals |
Privatisation; internet |
| Haier’s H-share issue, privatisation of Haier Electronics |
2020 |
N/A |
Overseas Deals |
Privatisation; Hong Kong listing |
| Kingsoft Cloud’s US IPO |
2020 |
USD551.3 million |
Overseas Deals |
Nasdaq IPO; cloud provider |
| SMIC’s A-share listing on Star board |
2020 |
RMB53.2 billion |
Deals in China |
Star board listing |
| Xpeng’s US IPO and USD1.3 billion pre-IPO financing |
2020 |
USD1.3 billion |
Overseas Deals |
IPO; financing; automobile |
| Yuanfudao G-round financing |
2020 |
USD1 billion |
Overseas Deals |
Financing; internet |
| Alibaba Group’s Hong Kong IPO |
2019 |
HKD88 billion |
Overseas Deals |
Hong Kong IPO; e-commerce |
| Apple and Qualcomm’s antitrust disputes |
2019 |
RMB1 billion |
Disputes & Investigations |
Patent litigation; antitrust |
| CR Micro’s A-share listing on Star board |
2019 |
N/A |
Deals in China |
SSE Star board listing |
| Eddingpharm Group acquires Eli Lilly China rights |
2019 |
USD375 million |
Deals in China |
Acquisition; pharmaceutical |
| Huatai Securities’ listing in London via Shanghai-London Stock Connect |
2019 |
N/A |
Overseas Deals |
UK listing; securities |
| Jinxin Fertility Group’s HK IPO |
2019 |
HKD3.05 billion |
Overseas Deals |
Hong Kong IPO; healthcare |
| NFC acquires United Family Healthcare |
2019 |
USD1.3 billion |
Deals in China |
Acquisition; pharmaceutical |
| PBOC renminbi bill issuances in HK |
2019 |
RMB160 billion |
Overseas Deals |
Capital markets |
| Alibaba privatizes and takes over Youku Tudou |
2016 |
N/A |
Deals in China |
M&A in China; privatization; TMT |
| BTG Hotels'srestructuring and acquisition of Home Inns Group |
2016 |
N/A |
Deals in China |
Asset restructuring; hotel industry; privatization |
| ChemChina acquires Syngenta |
2016 |
USD43 billion |
Overseas Deals |
Overseas M&A; technology |
| CRRC issues H-share convertible bonds |
2016 |
N/A |
Overseas Deals |
Convertible bonds; high-end manufacturing |
| Didi Chuxing M@A with Uber China |
2016 |
USD35 billion |
Deals in China |
M&A in China; TMT |
| Foxconn Industrial Internet’ A-share IPO |
2018 |
RMB27.12 billion |
Deals in China |
PRC capital market |
| GLP’s privatization |
2018 |
USD11.64 billion |
Overseas Deals |
Privatization; Logistics |
| Joint reorganization of Shenhua Group and China Guodian Corporation |
2018 |
RMB1.8 trillion |
Deals in China |
Reorganization; SOE |
| PRC Ministry of Finance issues US dollar sovereign bonds |
2017 |
USD2 billion |
Overseas Deals |
Sovereign bond |
| Qihoo 360 Technology goes private |
2016 |
USD9.3 billion |
Overseas Deals |
Private equity; privatization; TMT |
| Qudian's IPO on New York Stock Exchange |
2017 |
N/A |
Overseas Deals |
Overseas listing; Fintech |
| SenseTime’s series C/C+ round financing |
2018 |
USD1.22 billion |
Deals in China |
PE/VC; AI |
| Suning Sports’ series A financing |
2018 |
USD600 million |
Deals in China |
Financing; sports |
| WuXi Biologics'sHong Kong IPO |
2017 |
N/A |
Overseas Deals |
Overseas listing; Biotechnology |
| Alibaba Group’s debut notes offering |
2015 |
USD8 billion |
Debt capital marke |
Debt capital marke |
| Alibaba Group’s investment in Suning |
2015 |
USD4.4 billion |
Deals in China |
M&A |
| Alibaba Group’s investment in Youku Tudou |
2014 |
USD1.22 billion |
Deals in China |
M&A |
| Alibaba Group’s NYSE IPO |
2014 |
USD25 billion |
Overseas Deals |
Equity capital market |
| Alibaba’s acquisition of an 18% stake in Sina’s Weibo |
2013 |
USD586 million |
Deals in China |
M&A |
| Baidu’s acquisition of 91 Wireless |
2013 |
USD1.9 billion |
Deals in China |
M&A |
| Bayer’s acquisition of a 100% stake of Dihon |
2015 |
USD560 million |
Deals in China |
M&A |
| Didi Dache’s merger with Kuaidi Dache |
2015 |
USD6 billion |
Deals in China |
M&A |
| Focus Media’s backdoor listing on A-share market |
2015 |
N/A |
Take private |
Take private |
| Focus Media’s delisting from Nasdaq |
2013 |
USD3.7 billion |
Take private |
Take private |
| Giant Interactive’s take private transaction |
2014 |
USD3 billion |
Take private |
Take private |
| New China Life’s investment in Asia-Germany Industry 4.0 Promotion Cross-border Fund |
2015 |
N/A |
Debt capital marke |
Debt capital marke |
| Shuanghui’s acquisition of Smithfield |
2013 |
USD7.1 billion |
Overseas Deals |
M&A |
| Syndicated loan for a refining and ethylene expansion project in Fujian |
2013 |
USD720 million |
Banking & Finance |
Banking & Finance |
| TPG’s sale of its 100% stake in UT Capital Group to Haitong |
2013 |
USD7.15 million |
Private equity & venture capital |
Private equity & venture capital |
| Trina Solar’s convertible senior notes |
2014 |
USD150 million |
Debt capital market |
Debt capital market |
| TutorGroup’s subscription of Series B preferred equity |
2014 |
USD80 million |
Private equity & venture capital |
Private equity & venture capital |
| WuXi PharmaTech’s privatization |
2015 |
USD3.3 billion |
Take private |
Take private |
| Cinda receives strategic investment from CITIC, UBS, etc. |
2012 |
USD1.66 billion |
Deals in China |
M&A |
| hiSoft's proposed merger with VanceInfo |
2012 |
USD875 million |
Deals in China |
M&A |
| Youku and Tudou merger |
2012 |
USD 1.1 billion |
Deals in China |
M&A |
| Alibaba's privatisation and repurchase of half of Yahoo's stake |
2012 |
USD9.6 billion |
Take private |
Take private |
| Alibaba's privatisation and repurchase of half of Yahoo's stake |
2012 |
USD9.6 billion |
Take private |
Take private |
| Baosteel offers RMB bonds in Hong Kong |
2012 |
USD1 billion |
Capital market |
debt |
| China v ConocoPhillips in a sea pollution claim |
2012 |
USD269 million |
Dispute resolution |
Dispute resolution |
| CITIC Dicastal Wheel Manufacturing acquires German casting company |
2011 |
USD348 million |
Overseas Deals |
M&A |
| Goldman Sachs buys AXA’s stake in Taikang Life |
2011 |
USD940 million |
Private Equity & Venture Capital |
Private Equity & Venture Capital |
| Bain buys China Fire & Security |
2011 |
USD265 million |
Private Equity & Venture Capital |
Private Equity & Venture Capital |
| China Ming Yang Wind Power Group IPO |
2010 |
USD350 million |
Overseas Deals |
Capital markets;listings |
| China Minzhong Food Corporation IPO |
2010 |
SD236.8 million |
Overseas Deals |
Capital markets;listings |
| China Eastern Airlines-Shanghai Airlines merger |
2010 |
RMB9 billion |
Deals in China |
M&A |
